Company Overview

Update
Status:
Acquired by Cubist Pharmaceuticals
Headquarters:
San Diego, CA
IPO:
Went Public on Feb 9, 2007
Stock:
OPTR
Categories:
Biotechnology
Description:
Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on discovering, developing and commercializing

Detailed Description

Update

Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on discovering, developing and commercializing anti-infective products. It has two late-stage anti-infective product candidates, fidaxomicin and Pruvel (prulifloxacin). Optimer's development efforts are focused on products that treat gastrointestinal infections, and related diseases where therapies have limitations. Its product portfolio includes Fidaxomicin, Pruvel, CEM-101, OPT-822/OPT-821 Combination Therapy and OPT-88.

Current Team (4)

Update

Board Members and Advisors (1)

Update

Offices/Locations (2)

Update
  • Headquarters

    65 Hayden Avenue

    Lexington, 02421

  • Office

    10110 Sorrento Valley Rd.

    Suite C

    San Diego, CA 92121

    USA

Images (1)

Update
  • Luewxbvhjzve3jyunzqg